Prospects for a safe COVID-19 vaccine
BF Haynes, L Corey, P Fernandes, PB Gilbert… - Science translational …, 2020 - science.org
Rapid development of an efficacious vaccine against the viral pathogen severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of the coronavirus disease …
respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of the coronavirus disease …
Evaluation of the safety profile of COVID-19 vaccines: a rapid review
Q Wu, MZ Dudley, X Chen, X Bai, K Dong, T Zhuang… - BMC medicine, 2021 - Springer
Background The rapid process of research and development and lack of follow-up time post-
vaccination aroused great public concern about the safety profile of COVID-19 vaccine …
vaccination aroused great public concern about the safety profile of COVID-19 vaccine …
[HTML][HTML] [Comment] COVID‑19 vaccine safety
RN Kostoff, MB Briggs, AL Porter… - International …, 2020 - spandidos-publications.com
In response to the SARS‑CoV‑2 outbreak, and the resulting COVID‑19 pandemic, a global
competition to develop an anti‑COVID‑19 vaccine has ensued. The targeted time frame for …
competition to develop an anti‑COVID‑19 vaccine has ensued. The targeted time frame for …
Covid-19 vaccines—immunity, variants, boosters
DH Barouch - New England Journal of Medicine, 2022 - Mass Medical Soc
Covid-19 Vaccines — Immunity, Variants, Boosters | NEJM Skip to main content NEJM Group
Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician …
Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician …
COVID‐19 vaccinations: the unknowns, challenges, and hopes
K Mohamed, P Rzymski, MS Islam… - Journal of medical …, 2022 - Wiley Online Library
The entire world has been suffering from the coronavirus disease 2019 (COVID‐19)
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization
MK Patel, I Bergeri, JS Bresee, BJ Cowling… - Vaccine, 2021 - Elsevier
Phase 3 randomized-controlled trials have provided promising results of COVID-19 vaccine
efficacy, ranging from 50 to 95% against symptomatic disease as the primary endpoints …
efficacy, ranging from 50 to 95% against symptomatic disease as the primary endpoints …
COVID-19 vaccines currently under preclinical and clinical studies, and associated antiviral immune response
S Jain, H Batra, P Yadav, S Chand - Vaccines, 2020 - mdpi.com
With a death toll of over one million worldwide, the COVID-19 pandemic caused by SARS-
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
COVID-19: Mechanisms of vaccination and immunity
DE Speiser, MF Bachmann - Vaccines, 2020 - mdpi.com
Vaccines are needed to protect from SARS-CoV-2, the virus causing COVID-19. Vaccines
that induce large quantities of high affinity virus-neutralizing antibodies may optimally …
that induce large quantities of high affinity virus-neutralizing antibodies may optimally …
COVID-19 vaccines: concerns beyond protective efficacy and safety
CC Lai, IT Chen, CM Chao, PI Lee, WC Ko… - Expert review of …, 2021 - Taylor & Francis
Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
WY Chi, YD Li, HC Huang, TEH Chan, SY Chow… - Journal of biomedical …, 2022 - Springer
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …
challenge in this century. Two years after its emergence, the rapid development and …